Nov 24, 2024
Did Scientists Revive an Extinct Animal or Just Breed a Less Stripey Zebra?
Posted by Arthur Brown in category: futurism
A near four-decade quest to bring the quagga back is being heralded as a success, but not everyone is impressed.
Latest posts
Nov 24, 2024
Using light to create bioelectronics inside living organisms
Posted by Dan Breeden in categories: biotech/medical, neuroscience
Bioelectronics research and development of implants made of electrically conductive materials for disease treatment is advancing rapidly. However, bioelectronic treatment is not without complications. Researchers at Lund University in Sweden have taken another step forward by developing a refined method to create detailed and tissue-friendly bioelectronics.
In a study published in Advanced Science, the researchers describe how they can use light to create electrically conductive materials directly in the body, showing promising results in animal trials.
Bioelectronics is successfully used for treating heart arrhythmia, epilepsy, and neurodegenerative diseases like Parkinson’s, to name a few. However, it’s well known that today’s bioelectrodes and implantation methods require the tissue to adapt to the electrodes, rather than the other way around. This can lead to complications.
Nov 24, 2024
AI models work together faster when they speak their own language
Posted by Dan Kummer in categories: mathematics, robotics/AI
Letting AI models communicate with each other in their internal mathematical language, rather than translating back and forth to English, could accelerate their task-solving abilities.
Nov 24, 2024
RNA editing is the next frontier in gene therapy—here’s what you need to know
Posted by Genevieve Klien in categories: biotech/medical, life extension
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide.
This trial marks a new frontier in gene therapy —the process of treating or curing medical conditions by changing a person’s genes.
What makes it special is the fact the therapy targets RNA, instead of DNA. So, what does that mean, and why should we be excited?
Nov 24, 2024
Vitamins and Supplements to Fight Inflammation
Posted by Shubham Ghosh Roy in categories: food, health
Arthritis, intense exercise, and sugary or fatty foods are some of the things that can lead to inflammation. Here’s what you can take or add to your diet to help fight it.
Nov 24, 2024
Improving Army logistics with quantum computing
Posted by Shubham Ghosh Roy in categories: computing, quantum physics
Heeding those sentiments, the Australian Army is strategically investing in technological innovation to find better solutions to the complex logistics challenges they face in managing the efficient and safe deployment of personnel and equipment on the battlefield. For a difficult class of problems in an area called “optimization”, quantum computing is on the roadmap for exploration.
With the help of our quantum infrastructure software, they’ve now been able to test and validate a quantum computing solution on real hardware that promises to outperform their existing methods.
Nov 24, 2024
Unlocking Human Longevity: The Future of Life Extension Technologies
Posted by Shubham Ghosh Roy in categories: bioengineering, biotech/medical, life extension
Life extension technologies: Gene editing, Senolytics & more. Unlocking human longevity secrets.
Nov 24, 2024
RNA editing is the next frontier in gene therapy — here’s what you need to know
Posted by Shubham Ghosh Roy in category: biotech/medical
We can already tinker with human DNA to treat diseases. But being able to edit RNA allows for even more precision – and fewer risks.
Nov 24, 2024
DARPA?: DARPA is developing participatory sensing, swarm robotics and micro self-assembly…
Posted by Matthew Harris in category: robotics/AI
Nov 24, 2024
Influenza: Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses
Posted by Dan Breeden in category: biotech/medical
Influenza, commonly known as the flu, is an infectious disease caused by fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four (typically two) days after exposure to the virus and last for about two to eight days. Diarrhea and vomiting can occur, particularly in children. may progress to pneumonia from the virus or a subsequent bacterial infection. Other complications include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.
There are four types of virus: types A, B, C, and D. Aquatic birds are the primary source of epidemics, and C virus causes a mild infection, primarily in children. D virus can infect humans but is not known to cause illness. In humans, viruses are primarily transmitted through respiratory droplets from coughing and sneezing. Transmission through aerosols and surfaces contaminated by the virus also occur.
Frequent hand washing and covering one’s mouth and nose when coughing and sneezing reduce transmission, as does wearing a mask. Annual vaccination can help to provide protection against viruses, particularly A virus, evolve quickly, so flu vaccines are updated regularly to match which strains are in circulation. Vaccines provide protection against A virus subtypes H1N1 and H3N2 and one or two B virus subtypes. infection is diagnosed with laboratory methods such as antibody or antigen tests and a polymerase chain reaction (PCR) to identify viral nucleic acid. The disease can be treated with supportive measures and, in severe cases, with antiviral drugs such as oseltamivir. In healthy individuals, is typically self-limiting and rarely fatal, but it can be deadly in high-risk groups.
